Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer
Current standards for identifying recent cannabis use are based on body fluid testing. The Cognalyzer Seventy-five participants, aged 19-55 years, were enrolled, and oral fluid samples were collected pre-cannabis inhalation. EEG and subjective drug effects questionnaire (DEQ) were administered pre- and post-ad libitum cannabis inhalation. Fifty participants remained in the clinic for 4 h post-inhalation. Blinded analyses of the EEG files were conducted by Zentrela Inc. using two versions (V1 and V2) of the Cognalyzer The two versions of the Cognalyzer The Cognalyzer